Found: 41
Select item for more details and to access through your institution.
A Phase I Multicenter Study of Continuous Oral Administration of Lonafarnib (SCH 66336) and Intravenous Gemcitabine in Patients With Advanced Cancer.
- Published in:
- Cancer Investigation, 2011, v. 29, n. 9, p. 617, doi. 10.3109/07357907.2011.621912
- By:
- Publication type:
- Article
A Phase I Study of Eniluracil/5-FU in Combination with Radiation Therapy for Potentially Resectable and/or Unresectable Cancer of the Pancreas and Distal Biliary Tract.
- Published in:
- Cancer Investigation, 2006, v. 24, n. 1, p. 9, doi. 10.1080/07357900500449454
- By:
- Publication type:
- Article
Immunotherapy with autologous, human dendritic cells transfected with carcinoembryonic antigen mRNA.
- Published in:
- 2003
- By:
- Publication type:
- journal article
An Intervention to Improve Cancer Patients' Understanding of Early-Phase Clinical Trials.
- Published in:
- IRB: Ethics & Human Research, 2009, v. 31, n. 3, p. 1
- By:
- Publication type:
- Article
Does preoperative therapy optimize outcomes in patients with resectable pancreatic cancer?
- Published in:
- Journal of Surgical Oncology, 2012, v. 106, n. 1, p. 111, doi. 10.1002/jso.23044
- By:
- Publication type:
- Article
Genetic variation determines VEGF-A plasma levels in cancer patients.
- Published in:
- Scientific Reports, 2018, v. 8, n. 1, p. 1, doi. 10.1038/s41598-018-34506-4
- By:
- Publication type:
- Article
Bevacizumab exposure beyond first disease progression in patients with metastatic colorectal cancer: analyses of the ARIES observational cohort study.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2014, v. 23, n. 7, p. 726, doi. 10.1002/pds.3633
- By:
- Publication type:
- Article
Assessment of Capecitabine and Bevacizumab With or Without Atezolizumab for the Treatment of Refractory Metastatic Colorectal Cancer: A Randomized Clinical Trial.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 2, p. e2149040, doi. 10.1001/jamanetworkopen.2021.49040
- By:
- Publication type:
- Article
Blood-based markers of efficacy and resistance to cetuximab treatment in metastatic colorectal cancer: results from CALGB 80203 (Alliance).
- Published in:
- Cancer Medicine, 2016, v. 5, n. 9, p. 2249, doi. 10.1002/cam4.806
- By:
- Publication type:
- Article
Modulation of circulating protein biomarkers following TRC105 (anti-endoglin antibody) treatment in patients with advanced cancer.
- Published in:
- Cancer Medicine, 2014, v. 3, n. 3, p. 580, doi. 10.1002/cam4.207
- By:
- Publication type:
- Article
Plasma-Based Measurements of Tumor Heterogeneity Correlate with Clinical Outcomes in Metastatic Colorectal Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 9, p. N.PAG, doi. 10.3390/cancers14092240
- By:
- Publication type:
- Article
A Phase II Study of Oxaliplatin, Dose-intense Capecitabine, and High-dose Bevacizumab in the Treatment of Metastatic Colorectal Cancer.
- Published in:
- Clinical Colorectal Cancer, 2011, v. 10, n. 3, p. 210, doi. 10.1016/j.clcc.2011.03.018
- By:
- Publication type:
- Article
The effect of different dosing regimens of motesanib on the gallbladder: a randomized phase 1b study in patients with advanced solid tumors.
- Published in:
- BMC Cancer, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1471-2407-13-242
- By:
- Publication type:
- Article
The effect of different dosing regimens of motesanib on the gallbladder: a randomized phase 1b study in patients with advanced solid tumors.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Effect of bevacizumab in older patients with metastatic colorectal cancer: pooled analysis of four randomized studies.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2010, v. 136, n. 5, p. 737, doi. 10.1007/s00432-009-0712-3
- By:
- Publication type:
- Article
Clinical outcomes of patients with advanced gastrointestinal stromal tumors: Safety and efficacy in a worldwide treatment-use trial of sunitinib.
- Published in:
- Cancer (0008543X), 2015, v. 121, n. 9, p. 1405, doi. 10.1002/cncr.29220
- By:
- Publication type:
- Article
A phase Ib study of the combination regorafenib with PF-03446962 in patients with refractory metastatic colorectal cancer (REGAL-1 trial).
- Published in:
- 2019
- By:
- Publication type:
- journal article
The effects of lapatinib on cardiac repolarization: results from a placebo controlled, single sequence, crossover study in patients with advanced solid tumors.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A phase I study of the safety and pharmacokinetics of edotecarin (J-107088), a novel topoisomerase I inhibitor, in patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2007, v. 59, n. 1, p. 139, doi. 10.1007/s00280-006-0267-9
- By:
- Publication type:
- Article
Analysis of age, estimated creatinine clearance and pretreatment hematologic parameters as predictors of fludarabine toxicity in patients treated for chronic lymphocytic leukemia: a CALGB (9011) coordinated intergroup study.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2002, v. 50, n. 1, p. 37, doi. 10.1007/s00280-002-0443-5
- By:
- Publication type:
- Article
Primary Tumor Location as a Prognostic Factor in Metastatic Colorectal Cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2015, v. 107, n. 3, p. 1, doi. 10.1093/jnci/dju427
- By:
- Publication type:
- Article
Primary tumor location as a prognostic factor in metastatic colorectal cancer.
- Published in:
- 2015
- By:
- Publication type:
- journal article
The effect of anti-VEGF therapy on immature myeloid cell and dendritic cells in cancer patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 8, p. 1115, doi. 10.1007/s00262-007-0441-x
- By:
- Publication type:
- Article
Association of k-ras, b-raf, and p53 Status With the Treatment Effect of Bevacizumab.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2005, v. 97, n. 13, p. 981, doi. 10.1093/jnci/dji174
- By:
- Publication type:
- Article
A phase Ib study of capecitabine and ziv-aflibercept followed by a phase II single-arm expansion cohort in chemotherapy refractory metastatic colorectal cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Cabozantinib and Panitumumab for RAS Wild‐Type Metastatic Colorectal Cancer.
- Published in:
- Oncologist, 2021, v. 26, n. 6, p. 465, doi. 10.1002/onco.13678
- By:
- Publication type:
- Article
Phase II Randomized Trial of Sequential or Concurrent FOLFOXIRI‐Bevacizumab Versus FOLFOX‐Bevacizumab for Metastatic Colorectal Cancer (STEAM).
- Published in:
- Oncologist, 2019, v. 24, n. 7, p. 921, doi. 10.1634/theoncologist.2018-0344
- By:
- Publication type:
- Article
A Phase I Trial of the IGF‐1R Antibody Ganitumab (AMG 479) in Combination with Everolimus (RAD001) and Panitumumab in Patients with Advanced Cancer.
- Published in:
- Oncologist, 2018, v. 23, n. 7, p. 782, doi. 10.1634/theoncologist.2016-0377
- By:
- Publication type:
- Article
Impact of primary tumour location on efficacy of bevacizumab plus chemotherapy in metastatic colorectal cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Metastatic Ampullary Adenocarcinoma Presenting as a Hydrocele: A Case Report.
- Published in:
- JOP Journal of the Pancreas, 2014, v. 15, n. 3, p. 266
- By:
- Publication type:
- Article
Efficacy and Safety of Bevacizumab in Metastatic Colorectal Cancer: Pooled Analysis From Seven Randomized Controlled Trials.
- Published in:
- Oncologist, 2013, v. 18, n. 9, p. 1004, doi. 10.1634/theoncologist.2013-0107
- By:
- Publication type:
- Article
Analysis of Early Hypertension and Clinical Outcome With Bevacizumab: Results From Seven Phase III Studies.
- Published in:
- Oncologist, 2013, v. 18, n. 3, p. 273, doi. 10.1634/theoncologist.2012-0339
- By:
- Publication type:
- Article
A Phase II Study of Capecitabine, Oxaliplatin, and Bevacizumab in the Treatment of Metastatic Esophagogastric Adenocarcinomas.
- Published in:
- Oncologist, 2013, v. 18, n. 3, p. 271, doi. 10.1634/theoncologist.2012-0404
- By:
- Publication type:
- Article
Treatment Patterns and Clinical Outcomes in Patients With Metastatic Colorectal Cancer Initially Treated with FOLFOX-Bevacizumab or FOLFIRI-Bevacizumab: Results From ARIES, a Bevacizumab Observational Cohort Study.
- Published in:
- Oncologist, 2012, v. 17, n. 12, p. 1486, doi. 10.1634/theoncologist.2012-0190
- By:
- Publication type:
- Article
Bevacizumab-Based Therapies in the First-Line Treatment of Metastatic Colorectal Cancer.
- Published in:
- Oncologist, 2012, v. 17, n. 4, p. 513, doi. 10.1634/theoncologist.2012-0003
- By:
- Publication type:
- Article
Maintenance Therapy for First-Line Metastatic Colorectal Cancer: Activity and Sustainability.
- Published in:
- 2012
- By:
- Publication type:
- Opinion
A Phase II Trial of Bevacizumab plus Everolimus for Patients with Refractory Metastatic Colorectal Cancer.
- Published in:
- Oncologist, 2011, v. 16, n. 8, p. 1131, doi. 10.1634/theoncologist.2011-0078
- By:
- Publication type:
- Article
The Clinical Benefit of Bevacizumab in Metastatic Colorectal Cancer Is Independent of K-ras Mutation Status: Analysis of a Phase III Study of Bevacizumab with Chemotherapy in Previously Untreated Metastatic Colorectal Cancer.
- Published in:
- Oncologist, 2009, v. 14, n. 1, p. 22, doi. 10.1634/theoncologist.2008-0213
- By:
- Publication type:
- Article
Health-Related Quality of Life Impact of Bevacizumab When Combined with Irinotecan, 5-Fluorouracil, and Leucovorin or 5-Fluorouracil and Leucovorin for Metastatic Colorectal Cancer.
- Published in:
- Oncologist, 2008, v. 13, n. 9, p. 1021, doi. 10.1634/theoncologist.2008-0003
- By:
- Publication type:
- Article
Monoclonal Antibodies to EGFR: What Does the Future Hold?
- Published in:
- Oncology (08909091), 2007, v. 21, n. 8, p. 976
- By:
- Publication type:
- Article
A clinical model of dermal wound angiogenesis.
- Published in:
- Wound Repair & Regeneration, 2003, v. 11, n. 4, p. 306, doi. 10.1046/j.1524-475X.2003.11411.x
- By:
- Publication type:
- Article